🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these profiles directly for source information, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with numerous of members share comparison images, injection guides and assertions of rapid UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Some experts said the demand for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Removal

According to TikTok, the platform has removed problematic material and banned associated keywords and search suggestions. The organization stated it was committed to maintaining the platform safe and investing in enhancing compliance measures.

Digital Trading Operations

Investigations also discovered communities with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, positive reviews and step-by-step instructions for mixing or administering at home.

After moments of entering one community, a seller shared contact information, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Product Information and Pricing

Within these communities, messages show black plastic parcels with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram said it regularly monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they can’t verify. Although the research behind this drug is valid, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her staff has already seen patients harmed by personal administration from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may subject patients to possibly significant health risks”.